Medical Ikkou Group Co.,Ltd.
Stock Price Chart
2026/10/09 19:27 UpdatedPrice Trend
2026/10/09 19:27 UpdatedPrice & Trading Details
2026/10/09 19:27 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/10/01Dividend History 3Years Growth
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥120 | +20.0% |
| 2025 | ¥100 | +100.0% |
| 2024 | ¥50 | +25.0% |
| 2023 | ¥40 | 0.0% |
| 2022 | ¥40 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥33,898M | ¥39,901M | ¥48,393M | ¥54,983M |
| Gross Profit | ¥3,183M | ¥4,552M | ¥5,744M | ¥6,486M |
| Operating Income | ¥935M | ¥1,559M | ¥1,692M | ¥1,788M |
| Pretax Income | ¥1,365M | ¥1,717M | ¥1,965M | ¥2,127M |
| Net Income | ¥760M | ¥1,040M | ¥1,133M | ¥1,275M |
| EPS | ¥202.20 | ¥276.70 | - | - |
| Operating Margin | 2.76% | 3.91% | 3.50% | 3.25% |
| Balance Sheet | ||||
| Total Assets | ¥27,506M | ¥31,659M | ¥34,232M | ¥37,576M |
| Total Equity | ¥12,049M | ¥13,241M | ¥14,098M | ¥15,685M |
| Total Liabilities | ¥15,456M | ¥18,419M | ¥20,134M | ¥21,891M |
| Cash | ¥6,443M | ¥7,700M | ¥6,769M | ¥6,122M |
| Interest-bearing Debt | ¥9,118M | ¥9,579M | ¥10,018M | ¥10,364M |
| Equity Ratio | 43.81% | 41.82% | 41.18% | 41.74% |
| D/E Ratio | 0.76 | 0.72 | 0.71 | 0.66 |
| Cash Flow | ||||
| Operating CF | ¥1,308M | ¥4,277M | ¥1,198M | ¥1,208M |
| Investing CF | -¥478M | -¥3,219M | -¥1,135M | -¥1,814M |
| Financing CF | -¥2,367M | ¥278M | -¥1,028M | -¥284M |
| Free CF | ¥960M | ¥3,953M | ¥163M | ¥656M |
| Efficiency | ||||
| ROE | 6.30% | 7.85% | 8.04% | 8.13% |
| ROA | 2.76% | 3.28% | 3.31% | 3.39% |
Latest IR Information
-
Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending February 2027 [Japanese GAAP] (Consolidated)
Consolidated net sales for the interim period were 28,255 million yen, up 4.9% year-over-year. Operating income was 821 million yen, up 10.4% YoY; ordinary income was 1,135 million yen; and net income attributable to owners of the parent was 850...
Read more -
Notice Regarding Distribution of Surplus (Interim Dividend)
An interim dividend of 60 yen per share was announced. Record date: 2026-08-31, Effective date: 2026-11-05. Annual dividend is maintained at 60 yen based on past results and the latest forecast. The company aims for a dividend payout ratio of...
Read more -
Q1 FY2027 Financial Summary (Japan GAAP) (Consolidated)
Announces the consolidated results for Q1 of FY2027. Discloses changes in revenue compared with the prior year’s period, along with trends in operating income, ordinary income, and net income attributable to owners of the parent. Presents segment revenue and profit...
Read more
Latest News (5 items)
Company Information
About
Medical Ikkou Group Co.,Ltd. operates dispensing pharmacies in Japan. It also offers in residential nursing homes, such as paid nursing homes and group homes. In addition, the company provides sales activities specializing in the sale of generic drugs to medical institutions; and dispensing pharmacy business; pharmaceutical wholesale, real estate, and investment business. Medical Ikkou Group Co.,Ltd. was founded in 1980 and is headquartered in Tsu, Japan.
